Literature DB >> 25406339

Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.

Takahisa Kawakami1, Ivan G Gomez1, Shuyu Ren2, Kelly Hudkins3, Allie Roach2, Charles E Alpers3, Stuart J Shankland3, Vivette D D'Agati4, Jeremy S Duffield5.   

Abstract

FSGS is a heterogeneous fibrosing disease of the kidney, the cause of which remains poorly understood. In most cases, there is no effective treatment to halt or retard progression to renal failure. Increasing evidence points to mitochondrial dysfunction and the generation of reactive oxygen species in the pathogenesis of CKD. Autophagy, a major intracellular lysosomal degradation system, performs homeostatic functions linked to metabolism and organelle turnover. We prevented normal autophagic pathways in nephrons of mice by mutating critical autophagy genes ATG5 or ATG7 during nephrogenesis. Mutant mice developed mild podocyte and tubular dysfunction within 2 months, profound glomerular and tubular changes bearing close similarity to human disease by 4 months, and organ failure by 6 months. Ultrastructurally, podocytes and tubular cells showed vacuolization, abnormal mitochondria, and evidence of endoplasmic reticulum stress, features that precede the appearance of histologic or clinical disease. Similar changes were observed in human idiopathic FSGS kidney biopsy specimens. Biochemical analysis of podocytes and tubules of 2-month-old mutant mice revealed elevated production of reactive oxygen species, activation of endoplasmic reticulum stress pathways, phosphorylation of p38, and mitochondrial dysfunction. Furthermore, cultured proximal tubule cells isolated from mutant mice showed marked mitochondrial dysfunction and elevated mitochondrial reactive oxygen species generation that was suppressed by a mitochondrial superoxide scavenger. We conclude that mitochondrial dysfunction and endoplasmic reticulum stress due to impaired autophagic organelle turnover in podocytes and tubular epithelium are sufficient to cause many of the manifestations of FSGS in mice.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  Autophagy; focal segmental glomerulosclerosis; mitochondria

Mesh:

Substances:

Year:  2014        PMID: 25406339      PMCID: PMC4413752          DOI: 10.1681/ASN.2013111202

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  35 in total

Review 1.  Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications.

Authors:  Tatsuya Kuroki; Keiji Isshiki; George L King
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

2.  The melanoma-associated transmembrane glycoprotein Gpnmb controls trafficking of cellular debris for degradation and is essential for tissue repair.

Authors:  Bing Li; Ana P Castano; Thomas E Hudson; Brian T Nowlin; Shuei-Liong Lin; Joseph V Bonventre; Kenneth D Swanson; Jeremy S Duffield
Journal:  FASEB J       Date:  2010-08-13       Impact factor: 5.191

3.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.

Authors:  Björn Hartleben; Markus Gödel; Catherine Meyer-Schwesinger; Shuya Liu; Theresa Ulrich; Sven Köbler; Thorsten Wiech; Florian Grahammer; Sebastian J Arnold; Maja T Lindenmeyer; Clemens D Cohen; Hermann Pavenstädt; Dontscho Kerjaschki; Noboru Mizushima; Andrey S Shaw; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

Review 4.  Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Authors:  M M Löwik; P J Groenen; E N Levtchenko; L A Monnens; L P van den Heuvel
Journal:  Eur J Pediatr       Date:  2009-06-27       Impact factor: 3.183

5.  A protein conjugation system essential for autophagy.

Authors:  N Mizushima; T Noda; T Yoshimori; Y Tanaka; T Ishii; M D George; D J Klionsky; M Ohsumi; Y Ohsumi
Journal:  Nature       Date:  1998-09-24       Impact factor: 49.962

Review 6.  Therapy for fibrotic diseases: nearing the starting line.

Authors:  Scott L Friedman; Dean Sheppard; Jeremy S Duffield; Shelia Violette
Journal:  Sci Transl Med       Date:  2013-01-09       Impact factor: 17.956

7.  Bax inhibitor 1 regulates ER-stress-induced ROS accumulation through the regulation of cytochrome P450 2E1.

Authors:  Hyung-Ryong Kim; Geum-Hwa Lee; Eun Yi Cho; Soo-Wan Chae; Taeho Ahn; Han-Jung Chae
Journal:  J Cell Sci       Date:  2009-04-15       Impact factor: 5.285

8.  Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice.

Authors:  Masaaki Komatsu; Satoshi Waguri; Takashi Ueno; Junichi Iwata; Shigeo Murata; Isei Tanida; Junji Ezaki; Noboru Mizushima; Yoshinori Ohsumi; Yasuo Uchiyama; Eiki Kominami; Keiji Tanaka; Tomoki Chiba
Journal:  J Cell Biol       Date:  2005-05-02       Impact factor: 10.539

9.  The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species.

Authors:  R M Zwacka; A Reuter; E Pfaff; J Moll; K Gorgas; M Karasawa; H Weiher
Journal:  EMBO J       Date:  1994-11-01       Impact factor: 11.598

10.  TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury.

Authors:  Gabriela Campanholle; Kristen Mittelsteadt; Shunsaku Nakagawa; Akio Kobayashi; Shuei-Liong Lin; Sina A Gharib; Jay W Heinecke; Jessica A Hamerman; William A Altemeier; Jeremy S Duffield
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

View more
  69 in total

Review 1.  Protecting Podocytes: A Key Target for Therapy of Focal Segmental Glomerulosclerosis.

Authors:  Kirk N Campbell; James A Tumlin
Journal:  Am J Nephrol       Date:  2018-05-31       Impact factor: 3.754

Review 2.  APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Authors:  Pazit Beckerman; Katalin Susztak
Journal:  Trends Mol Med       Date:  2018-06-07       Impact factor: 11.951

3.  Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Authors:  Pazit Beckerman; Jing Bi-Karchin; Ae Seo Deok Park; Chengxiang Qiu; Patrick D Dummer; Irfana Soomro; Carine M Boustany-Kari; Steven S Pullen; Jeffrey H Miner; Chien-An A Hu; Tibor Rohacs; Kazunori Inoue; Shuta Ishibe; Moin A Saleem; Matthew B Palmer; Ana Maria Cuervo; Jeffrey B Kopp; Katalin Susztak
Journal:  Nat Med       Date:  2017-02-20       Impact factor: 53.440

Review 4.  Drug discovery in focal and segmental glomerulosclerosis.

Authors:  Nick Pullen; Alessia Fornoni
Journal:  Kidney Int       Date:  2016-04-23       Impact factor: 10.612

5.  Glomerular disease: autophagy failure and mitochondrial dysfunction in FSGS.

Authors:  Ellen F Carney
Journal:  Nat Rev Nephrol       Date:  2014-12-09       Impact factor: 28.314

6.  Glomerular Effects of Age and APOL1.

Authors:  Timothy W Meyer; Colin R Lenihan
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

7.  Could Autophagic Exhaustion Be a Final Common Pathway for Podocytopathy in FSGS?

Authors:  Manjeri A Venkatachalam
Journal:  J Am Soc Nephrol       Date:  2014-11-18       Impact factor: 10.121

8.  The unfolded protein response in relation to mitochondrial biogenesis in skeletal muscle cells.

Authors:  Zahra S Mesbah Moosavi; David A Hood
Journal:  Am J Physiol Cell Physiol       Date:  2017-03-08       Impact factor: 4.249

Review 9.  Stem cell-based treatment of kidney diseases.

Authors:  Binbin Pan; Guoping Fan
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-11

Review 10.  The role of extracellular vesicles in podocyte autophagy in kidney disease.

Authors:  Baichao Sun; Shubo Zhai; Li Zhang; Guangdong Sun
Journal:  J Cell Commun Signal       Date:  2021-02-22       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.